Anatomic pathology studies tissues and organs, usually through surgical specimens, biopsies and autopsies, and examines them grossly and under the microscope to identify disease. Clinical laboratory medicine, sometimes called clinical pathology, analyzes body fluids and cells such as blood, urine and cerebrospinal fluid using chemistry, hematology, microbiology, immunology and molecular methods. Both disciplines share the goal of providing diagnostic information that guides treatment, but they rely on different specimens and techniques. In practice, a hospital may use anatomic findings to confirm a tumor type while clinical laboratory results monitor treatment response, so the two areas often work together on the same patient.
A clinical laboratory usually includes pathologists, who are physicians responsible for interpreting results and advising clinicians, along with laboratory scientists, technologists and technicians who perform testing and validate analytical quality. Phlebotomists collect specimens, while laboratory managers oversee operations, staffing and compliance. Pathologists often hold board certification and direct the medical content of testing. Each role carries distinct responsibilities, and understanding them helps clinicians know whom to contact about a result, a specimen problem or an unexpected finding. Professional titles and credentials vary by country and employer, so readers should confirm local requirements through their licensing authority.
Laboratory results are only as reliable as the specimen they are based on. Errors in collection, labeling, timing, container choice or transport can change measured values or make a test impossible to perform. For example, leaving a blood sample at room temperature can alter potassium levels, while drawing blood from an arm receiving intravenous fluid can dilute the sample and falsely lower results. Mislabeled specimens create identification errors that may lead to wrong treatment. Laboratories therefore publish collection procedures, check specimen acceptability on arrival and reject samples that cannot give valid answers, with the reason reported to the ordering clinician.
A reference interval is the range of values expected in a defined healthy population, commonly set to include about ninety-five percent of reference individuals. Because measured values depend on the analytical method, instrument and population characteristics such as age, sex and pregnancy, reference intervals are not universal. A laboratory should establish or verify its own intervals when it changes methods or serves a different population. A result outside the interval is not automatically disease, and a value inside the interval does not exclude it. Clinicians therefore interpret results alongside symptoms, history and trends, using the intervals printed on each report.
A complete blood count measures red cells, white cells and platelets, along with indices that describe cell size and hemoglobin content. Low hemoglobin with small red cells may suggest iron deficiency, while large cells can point to vitamin B12 or folate problems. An elevated white cell count often accompanies infection or inflammation, and a differential breakdown can suggest bacterial, viral or allergic causes. A low platelet count raises bleeding risk and may prompt a peripheral smear review. Interpretation depends on the whole clinical picture, and any findings suggesting serious disease should be reviewed by a qualified clinician rather than acted on from a report alone.
Clinical chemistry measures substances in blood and urine that reflect organ function and metabolism. Creatinine and estimated glomerular filtration rate help estimate kidney function, while enzymes such as alanine aminotransferase and bilirubin reflect liver cell injury and excretion. Glucose and hemoglobin A1c support diagnosis and monitoring of diabetes. Electrolytes like sodium and potassium reveal fluid and acid-base disturbances. These tests are most useful when repeated over time, since a single abnormal value may be transient. Interpretation should consider medications, hydration, fasting status and assay limitations, and any significant abnormality warrants prompt evaluation by the treating clinician.
After surgical removal or biopsy, tissue is fixed, usually in formalin, to preserve its structure and prevent decay. The specimen is then processed by dehydration, clearing and infiltration with paraffin wax, embedded in a block, and cut into very thin sections about a few micrometers thick. These sections are mounted on glass slides and stained, most often with hematoxylin and eosin, to highlight cell nuclei and cytoplasm. Special stains and immunohistochemistry may be added to identify specific proteins. Each step affects diagnostic quality, so fixation time and staining consistency are monitored carefully by laboratory staff.
Cytology examines individual cells collected by swab, brush or aspiration to identify changes that may indicate precancer or cancer. In cervical screening, cells from the cervix are placed on a slide or in liquid medium and reviewed for abnormal nuclear features. Cytology is valuable because it is minimally invasive and can detect changes early, allowing timely referral for further testing. Its accuracy is limited by sampling error, since an abnormal area may be missed, and by the subjective nature of cell interpretation. Results are therefore combined with clinical guidelines, human papillomavirus testing where used, and follow-up procedures set by national programs.
Culturing allows the laboratory to grow and identify the microorganisms responsible for an infection, such as bacteria or fungi, from a clinical specimen. Once an organism is identified, susceptibility testing determines which antimicrobial agents are likely to be effective against it. This information guides clinicians toward appropriate treatment and helps limit unnecessary broad-spectrum antibiotic use. Results take time, so empirical treatment is often started first and adjusted when findings return. Laboratories follow established standards for test methods and interpretive criteria, and treatment decisions remain the responsibility of the prescribing clinician in light of the patient's condition and local resistance patterns.
Molecular diagnostics detect specific nucleic acid sequences, DNA or RNA, that reveal an infection or inherited or acquired genetic variant. Polymerase chain reaction amplifies a target sequence many times so that a small amount of genetic material can be detected. Such tests can identify viruses that are hard to culture, detect resistance genes and support cancer classification, for example by finding gene mutations that determine eligibility for targeted therapy. Their high sensitivity also raises the risk of detecting trace or contaminating material, so results must be interpreted with knowledge of the clinical context and the test's performance characteristics.
Immunohistochemistry uses antibodies that bind to specific proteins within tissue sections, and a visible color reaction shows where those proteins are present. Pathologists use these stains to determine a tumor's cell lineage, distinguishing, for example, carcinoma from lymphoma when morphology alone is unclear. Some markers also predict response to particular therapies, such as hormone receptor status in breast cancer. Staining must be carefully controlled with positive and negative controls, since variation in fixation or antibody performance can change results. Scores are often reported with standardized criteria, and final interpretation integrates these findings with the full histologic picture.
Laboratory quality control involves running materials with known values alongside patient samples to confirm that a test is performing as expected. Control results are plotted against established limits, often using statistical rules, so that shifts or trends can be spotted early. When a control falls outside acceptable limits, the laboratory investigates the cause, which may involve reagents, calibration, instruments or environment, before releasing patient results. Quality control is complemented by external proficiency testing, where samples are compared across laboratories. Together these measures protect accuracy, and laboratories document corrective actions to support continuous improvement.
Studies of laboratory error have repeatedly found that many problems arise in the preanalytical phase, which covers ordering, identification, collection, transport and handling of specimens, rather than in the analytical measurement. Common examples include wrong patient identification, hemolyzed samples, incorrect tube types and delays in transport. Laboratories reduce these risks by using standardized order sets, barcode labeling, clear collection instructions for staff and clinicians, and automated checks for specimen quality. Feedback loops that report errors back to collection sites are also effective. Because the sources of error are often outside the laboratory, cooperation with nursing and clinical teams is essential.
Incident reporting allows staff to record errors, near misses and adverse events so the organization can analyze causes and prevent recurrence. In a laboratory, a reported event might involve a mislabeled specimen, a delayed critical result or an instrument malfunction. Reports are most useful when they are reviewed without blame, focusing on system weaknesses such as confusing labels or poor workflow design. Effective programs track trends, share lessons learned and verify that corrective actions work. Reporting requirements and confidentiality protections differ by jurisdiction, so staff should follow their institution's policy and applicable regulations.
Critical values are results so abnormal that they may indicate an immediate threat to life, such as severely low potassium or a very high glucose level. Laboratories define these thresholds with clinical input and aim to notify the responsible clinician promptly, often within a set time frame. Notification should identify the patient correctly, state the value and the time, and be documented, including the name of the person who received the call. Read-back of the result is commonly used to confirm accuracy. Clear procedures ensure that when a patient is seriously ill, the information reaches someone able to act on it.
Laboratory staff handle specimens that may contain bloodborne or airborne pathogens, so they rely on standard precautions that treat all specimens as potentially infectious. These include hand hygiene, appropriate personal protective equipment such as gloves and gowns, and safe handling of sharps. Work that can generate aerosols, such as centrifuging or opening samples, is performed in biosafety cabinets when indicated. Laboratories with higher-risk organisms follow containment levels defined in recognized biosafety guidance. Vaccination programs, waste disposal procedures and exposure follow-up plans complete the framework. Staff should always follow their facility's written safety procedures and occupational health guidance.
17
Documentation and records
Why must laboratory records be complete, traceable and retained, and what should they include?
Laboratory records document each step from specimen receipt through analysis and reporting, creating a traceable history that supports patient care, quality review and legal accountability. A complete record typically includes patient identifiers, specimen type and collection time, test methods, instrument identifiers, quality control results, the reported value, the reviewing individual and any amendments. Corrections should be made transparently, with the original result retained and the reason recorded. Retention periods are set by law and accreditation standards and vary by jurisdiction. Good documentation allows a laboratory to investigate complaints and demonstrate that results were produced correctly.
Laboratory results are sensitive health information, and their handling is governed by privacy legislation and professional confidentiality duties. Access should be limited to individuals who need the information to provide care or perform laboratory operations, and disclosure to third parties requires an appropriate legal basis or patient consent. Electronic systems use authentication, audit trails and encryption to protect records, while printed reports should be handled securely. Laboratories also consider how results are shared through patient portals or when sending results to other providers. Specific obligations depend on the jurisdiction, so staff must follow their organization's privacy policies and seek guidance from data protection officers when unsure.
Stored specimens can be valuable for research, quality improvement and future diagnostics, but their use raises questions about consent, privacy and the patient's expectations. Many institutions distinguish between clinical use, which is generally covered by the purpose of collection, and secondary use for research, which may require explicit consent or an approved waiver by an ethics committee. Specimens may be de-identified or coded to protect confidentiality, although re-identification risks must be considered. Patients should be able to ask how their samples are used and to withdraw where policies allow. Requirements vary by country and by study type, so institutions should consult their ethics and governance bodies before secondary use.
Clinical laboratories typically operate under regulatory and accreditation frameworks that set requirements for personnel qualifications, test validation, quality management, proficiency testing and inspection. Compliance is verified through licensing, accreditation surveys and periodic audits, and deficiencies may lead to corrective action or loss of certification. These frameworks cover both the analytical quality of tests and the management systems supporting them. The specific authorities, requirements and transitional rules depend on the country and region, and laboratory leaders must track current regulations. Staff should treat published standards as the minimum expectation and consult the relevant regulator or accrediting body when planning changes.